SCHEMBL4249541

SCHEMBL4249541

C[C@H]([C@H](C)P(c1ccccc1)c1ccccc1)P(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.45
CYP3A4 P08684 1/20 0.45
ESR1 P03372 4/20 0.37
ESR2 Q92731 4/20 0.37
TAAR1 Q96RJ0 4/20 0.33
SLC6A2 P23975 2/20 0.33
LMNA P02545 2/20 0.33
MAOA P21397 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
TSHR P16473 1/20 0.33
ALOX12 P18054 1/20 0.33
ACHE P22303 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CYP2A6 P11509 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA2C P18825 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29178 1.00 TDP1 (0.45) TDP1CYP3A4ESR1ESR2TAAR1
SCHEMBL30147 1.00 TDP1 (0.45) TDP1CYP3A4ESR1ESR2TAAR1
SCHEMBL12584889 1.00 TDP1 (0.45) TDP1CYP3A4ESR1ESR2TAAR1
SCHEMBL31588 1.00 TDP1 (0.45) TDP1CYP3A4ESR1ESR2TAAR1
SCHEMBL18832827 1.00 TDP1 (0.45) TDP1CYP3A4ESR1ESR2TAAR1
SCHEMBL30366682 0.97 TDP1 (0.43) TDP1CYP3A4ESR1ESR2TAAR1
Hydrochloric Acid SCHEMBL10627881 0.95 TDP1 (0.41) TDP1CYP3A4ESR1ESR2TAAR1
SCHEMBL10627887 0.90 TDP1 (0.38) TDP1CYP3A4ESR1ESR2
SCHEMBL14713495 0.89 TDP1 (0.41) TDP1CYP3A4ESR1ESR2TAAR1
SCHEMBL18294158 0.89 TDP1 (0.41) TDP1CYP3A4ESR1ESR2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556294-B2 Magnetic particle-polymer hybrid materials with functionalized polymers derived from norbornenyl reagents THE UNIVERSITY OF KANSAS (US) 2017-01-31 US disclosed
US-7973198-B2 Method for synthesizing optically active carbonyl compounds BASF SE (DE) 2011-07-05 US disclosed
US-20100152494-A1 METHOD FOR SYNTHESIZING OPTICALLY ACTIVE CARBONYL COMPOUNDS BASF SE (DE) 2010-06-17 US disclosed
US-7638654-B2 1-fluoro-1, 1-bis-(phenylsulfonyl)methane and production method thereof NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2009-12-29 US disclosed
US-20090131723-A1 1-Fluoro-1,1-Bis-(Phenylsulfonyl)Methane and Production Method Thereof TOSOH F-TECH, INC. (JP) 2009-05-21 US disclosed
EP-1992612-A1 1-FLUORO-1,1-BIS(PHENYLSULFONYL)METHANE AND METHOD FOR PRODUCING SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2008-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152494-A1 METHOD FOR SYNTHESIZING OPTICALLY ACTIVE CARBONYL COMPOUNDS HMOX1, HMOX2, CBR1 TDP1 4870/4885CYP3A4 428/4885ESR1 3106/4885
US-20090131723-A1 1-Fluoro-1,1-Bis-(Phenylsulfonyl)Methane and Production Method Thereof CYP2S1, ARSA, MSMO1 TDP1 3003/4885CYP3A4 148/4885ESR1 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.